Please use this identifier to cite or link to this item:
http://dspace.bits-pilani.ac.in:8080/jspui/xmlui/handle/123456789/13425Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Taliyan, Rajeev | - |
| dc.date.accessioned | 2023-12-14T09:26:42Z | - |
| dc.date.available | 2023-12-14T09:26:42Z | - |
| dc.date.issued | 2023-06 | - |
| dc.identifier.uri | https://alz-journals.onlinelibrary.wiley.com/doi/abs/10.1002/alz.065550 | - |
| dc.identifier.uri | http://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13425 | - |
| dc.description.abstract | Diabetes Mellitus is a metabolic disorder characterized by insulin resistance with several metabolic abnormalities which trigger neuronal complications, neurodegeneration, and cognitive impairments. Repaglinide (REP) is an insulinotropic, neuroprotective agent with short-action and poor absorption characteristics. Hence, the present study was aimed to investigate the efficacy of REP-loaded lipid polymer-hybrid nanoparticles (REP-LPHNPs) in High Fat Diet low dose of Streptozotocin (HFD-STZ) induced cognitive deficits wistar rats model. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Wiley | en_US |
| dc.subject | Pharmacy | en_US |
| dc.subject | Streptozotocin | en_US |
| dc.subject | Repaglinide (REP) | en_US |
| dc.title | Pre-Clinical Investigation of Repaglinide Nanoparticles in High Fat Diet with streptozotocin induced memory impaired rats | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | Department of Pharmacy | |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.